by Milka Sokolović | Jul 8, 2021 | #EU4Health, The View from EPHA, Universal Access and Affordable Medicines | Analysis & Opinion
The access to medicines debate in Europe is at a critical juncture. With the pandemic, all issues, old and new, suddenly find a place on the agenda. They range from the prices of medicines, the flexibility of regulatory standards, the quality of innovation, all the...
by Yannis Natsis | Jul 8, 2021 | Universal Access and Affordable Medicines | Analysis & Opinion
Undeniably, pharmaceutical companies’ power and influence have grown in the context of the current pandemic. The politicisation of pharmaceuticals is unprecedented. Pharma CEOs pick up the phone and talk directly to EU heads of state and governments. Companies are...
by European Public Health Alliance | Jul 8, 2021 | Universal Access and Affordable Medicines | Analysis & Opinion
Guest article: Ella Weggen & Marianne Meijer, Global Health Advovates, WemosTRIPS waiver, C-TAP, the use of compulsory licensing, donations through COVAX – various strategies have been proposed to increase global access to COVID-19 vaccines. One way or another,...
by European Public Health Alliance | Jul 8, 2021 | Universal Access and Affordable Medicines | Analysis & Opinion
By Jaume Vidal, Senior Policy Advisor, Health Action InternationalThe COVID-19 pandemic, and the efforts of governments and international organisations to counter it, has laid bare the pre-existing contradictions and shortcomings in the current biomedical research and...
by European Public Health Alliance | Mar 30, 2021 | Cancer, Universal Access and Affordable Medicines | Analysis & Opinion
Guest article: Lydie Meheus, Belgian AntiCancer FundTo fight cancer, Europe needs a whole-of-government approach that puts patients’ needs at the centre, driving change for the benefit of citizens and reducing the suffering caused by cancer. The Anticancer Fund...
by European Public Health Alliance | Nov 14, 2020 | Cancer, Universal Access and Affordable Medicines | Analysis & Opinion
Guest article | Lydie Meheus PhD, Managing Director, Belgian Anticancer FundCancer patients want to have access to the best available treatment and they want it fast, as in many cases they expect it to be lifesaving.Unfortunately, the current system to bring a new...
